^
+ Follow STROKE MONITORY SYSTEM Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 194372
                    [Title] => First treatment for acute ischaemic stroke launched
                    [Summary] => INGELHEIM, Germany – Boehringer Ingelheim has announced the European launch of Actilyse (altiplase) as the first and only treatment for acute ischaemic stroke after being approved by the European Commission.


The EC approved the use of the Actilyse treatment of selected patients with acute ischaemic stroke in the 0-3 hour window, based on the results of international clinical trials.
[DatePublished] => 2003-02-06 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
STROKE MONITORY SYSTEM
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 194372
                    [Title] => First treatment for acute ischaemic stroke launched
                    [Summary] => INGELHEIM, Germany – Boehringer Ingelheim has announced the European launch of Actilyse (altiplase) as the first and only treatment for acute ischaemic stroke after being approved by the European Commission.


The EC approved the use of the Actilyse treatment of selected patients with acute ischaemic stroke in the 0-3 hour window, based on the results of international clinical trials.
[DatePublished] => 2003-02-06 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with